ArticleTranslational psychiatry2025

LdIL-2 treatment in ASD: a novel immunotherapeutic approach targeting Th/Treg dysfunction and neuroinflammation.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.